Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Author Archives: Mission IR

Vivus, Inc. (VVUS) Starts Presentation at 25th Annual ROTH Conference

Vivus is a biopharmaceutical company focused on commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health for U.S., Europe and other world markets. The company offers Qsymia, which is in phase 2 … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

LeapFrog Enterprises, Inc. (LF) Starts Presentation at 25th Annual ROTH Conference

LeapFrog Enterprises is a leading developer of children’s educational entertainment. The company boasts an award-winning product portfolio aimed at helping children reach their potential. LeapFrog delivers best-in-class curriculum consisting of engaging content, toys and fun multimedia learning platforms. The company … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Lpath, Inc. (LPTN) Starts Presentation at 25th Annual ROTH Conference

Lpath is a therapeutic antibody company and an industry leader in lipid-targeted therapeutics. ImmuneY2, the company’s drug-discovery engine, has the singular ability to generate monoclonal antibodies that bind to and inhibit bioactive lipids, which contribute to disease. Based in San … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Datawatch Corporation (DWCH) Starts Presentation at 25th Annual ROTH Conference

Datawatch is a leading global provider of information optimization products and solutions that enable organizations to offer the greatest possible data variety in their big data and analytic applications. The company enables organizations to integrate structured, unstructured and semi-structured sources, … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Orbite Aluminae, Inc. (ORT) Starts Presentation at 25th Annual ROTH Conference

Orbite Aluminae develops proprietary clean technologies that allow the extraction of alumina and other high-value products, such as rare earths and rare metals, from various sources without generating the caustic waste. ORT is currently commissioning its first commercial high-purity alumina … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

EnteroMedics, Inc. (ETRM) Starts Presentation at 25th Annual ROTH Conference

EnteroMedics is a medical device company engaged in developing and commercializing its neuroscience-based technology for treating obesity and metabolic diseases. VBLOC vagal blocking therapy, the company’s proprietary technology, is delivered by a pacemaker-like device called the Maestro Rechargeable System and … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

DFC Global Corp. (DLLR) Starts Presentation at 25th Annual ROTH Conference

DFC Global is an international diversified financial services company chiefly serving unbanked and under-banked consumers. In business for over 30 years, DFC Global operates through more than 1,400 retail storefront locations, multiple Internet Web sites, and mobile phone and other remote … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Pixelworks, Inc. (PXLW) Starts Presentation at 25th Annual ROTH Conference

Pixelworks creates, develops and markets video display processing technology for digital video applications that demand the very highest quality images. At design centers around the world, PXLW engineers constantly push video performance to keep manufacturers of consumer electronics and professional … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Patient Safety Technologies, Inc. (PSTX) Starts Presentation at 25th Annual ROTH Conference

Patient Safety Technologies operates through its wholly owned subsidiary, SurgiCount Medical, Inc., to provide the Safety-Sponge® System, a solution clinically proven to improve patient safety and help prevent one of the most common errors in surgery: retained surgical sponges. The … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Nektar Therapeutics (NKTR) Starts Presentation at 25th Annual ROTH Conference

Nektar Therapeutics is a biopharmaceutical company engaged in the development of novel therapeutics based on the company’s PEGylation and advanced polymer conjugation technology platforms. The company’s R&D pipeline consists of potentially high-value therapeutics in pain, oncology and other therapeutic areas. NKTR’s … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment